A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group-Reference-Cited by-同舟云学术

A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group

Published:2013-06 Issue:4 Volume:16 Page:655-669
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Schulman Kathy L.,Berenson Karina,(Tina) Shih Ya-Chen,Foley Kathleen A.,Ganguli Arijit,de Souza Jonas,Yaghmour Nicholas A.,Shteynshlyuger Alex

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference321 articles.

1. Estimating health care costs related to cancer treatment from SEER-Medicare data;Brown;Med Care,2002

2. Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison;Chu;Clin Colorectal Cancer,2010

3. Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review;Henry;Support Care Cancer,2011

4. Patterns of bisphosphonate use in the United States in the treatment of metastatic bone disease;Mortimer;Clin Breast Cancer,2007

5. Economic burden of metastatic bone disease in the U.S;Schulman;Cancer,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data;Clinical Epidemiology;2023-01

2. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States;ESMO Open;2021-10

3. How to discriminate non-small cell lung cancer (NSCLC) cases from an Italian administrative database? A retrospective, secondary data use study for evaluating a novel algorithm performance;BMJ Open;2021-09

4. Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data;Pharmacoepidemiology and Drug Safety;2021-03-04

5. Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review;Value in Health;2020-11